Pinealon // Pineal Bioregulator
A Khavinson tripeptide bioregulator that targets pineal gland restoration to revive natural melatonin production. Instead of supplementing melatonin externally (which can suppress endogenous production), Pinealon addresses the upstream cause — restoring the pineal gland's ability to produce its own melatonin signal.
Restoring melatonin at the source.
Supplemental melatonin provides the hormone but can suppress your pineal gland's own production over time. Pinealon restores the gland itself — reactivating the epigenetic program for endogenous melatonin synthesis.
Burst protocol — 10 to 20 days.
Pinealon follows the Khavinson burst protocol. Short intensive courses trigger lasting epigenetic changes in pineal cells. 10–20 day bursts, repeated 2–4 times per year.
Khavinson's pineal restoration research.
Pinealon (EDR) was developed by Vladimir Khavinson as part of his bioregulator research program at the Saint Petersburg Institute of Bioregulation and Gerontology. It targets the pineal gland — the neuroendocrine organ responsible for melatonin synthesis.
Khavinson's research showed that pineal function declines significantly with age, contributing to circadian disruption, immune decline, and accelerated aging. Short peptide bioregulators that restore pineal gene expression could reverse these age-related changes.
The burst protocol approach is consistent with all Khavinson bioregulators — short courses trigger epigenetic changes that persist beyond the dosing period. Combined with DSIP for delta wave enhancement and Epithalon for telomerase activation, Pinealon forms part of the comprehensive Khavinson longevity protocol.
Sleep supplement comparison.
| Compound | Mechanism | Approach | Dependency | Duration |
|---|---|---|---|---|
| Pinealon | Pineal Restoration | Upstream fix | No | Burst protocol |
| Melatonin | Direct Supplement | Replacement | Can develop | Daily |
| DSIP | Delta Wave Enhancement | Architecture | No | Nightly cycle |
| Magnesium | GABA Support | Cofactor | No | Daily |
What to watch for.
Pinealon's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
- Extremely well tolerated
- Drowsiness if taken during daytime (take before bed)
- No known adverse effects in reported use
- Khavinson bioregulators have excellent safety profiles
- Short burst protocol limits exposure
- No dependency or withdrawal
- Melatonin levels (AM/PM — before and after burst)
- Cortisol AM
- Sleep study or wearable data
- Comprehensive metabolic panel
- DSIP for the Knockout Stack (pineal + delta waves)
- Epithalon for combined Khavinson bioregulator longevity protocol
- CJC-1295/Ipamorelin before bed for GH optimization
- Thymalin for immune bioregulator synergy
- Space different bioregulator bursts when possible
- Can replace exogenous melatonin supplementation
- Store in cool, dry place
- Oral capsules: room temperature
- SubQ lyophilized: refrigerate at 2–8°C
- Protect from moisture
- Tripeptide — relatively stable
Compounds that complement Pinealon.
Stop supplementing melatonin — restore the factory instead.
Pinealon addresses the root cause of age-related melatonin decline: pineal gland dysfunction. Rather than replacing melatonin externally (which can suppress endogenous production), Pinealon restores the gland's own ability to produce it. The Khavinson burst protocol is simple: 10–20 days, then months off while the epigenetic changes integrate. Combine with DSIP for the Knockout Stack — restored melatonin timing plus enhanced delta wave depth. Test melatonin levels before and after your first burst to verify response. If you've been taking exogenous melatonin for years and want to get off it, Pinealon is the exit strategy.
Our free Protocol Guide includes the Knockout Stack and Khavinson bioregulator burst protocols with sleep tracking templates.